Article: Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitors.
Archives of biochemistry and biophysics
2005 Volume 438, Issue 2, Page(s) 195–205
Abstract: c-Jun N-terminal kinase (JNK) activation is linked to the aberrant cell death in several neurodegenerative disorders, including Parkinson's and Alzheimer's disease. The sequence similarity among the JNK isoforms and fellow MAP kinase family member p38 ... ...
Abstract | c-Jun N-terminal kinase (JNK) activation is linked to the aberrant cell death in several neurodegenerative disorders, including Parkinson's and Alzheimer's disease. The sequence similarity among the JNK isoforms and fellow MAP kinase family member p38 has rendered the challenge of producing JNK3-specific inhibitors difficult. Using the crystal structure of JNK3 complexed with JNK inhibitors, potential compound-interacting amino acid residues were mutated to the corresponding residues in p38. The effects of these mutations on the kinetic parameters with three compounds were examined: a JNK3- (vs. p38-) selective inhibitor (SP 600125); a p38-selective inhibitor (Merck Z); and a potent combined JNK3 and p38 inhibitor (Merck Y). The data confirm the role of the JNK3 residues Ile-70 and Val-196 in both inhibitor and ATP-binding. Remarkably, the Ile-70-Val and Val-196-Ala mutations caused an increase and decrease, respectively, in the binding affinity of the p38-specific compound, Merck Z, of 10-fold. The Ile-70-Val effect may be due to the increased capacity of the active site to accommodate Merck Z, whereas the Val-196-Ala mutant may induce an unfavourable conformational change. Conservative mutations of the Asn-152 and Gln-155 residues inactivated the JNK3 enzyme, possibly interfering with protein folding in a critical hinge region of the protein. |
---|---|
MeSH term(s) | Adenosine Triphosphate/chemistry ; Alanine/chemistry ; Amino Acids/chemistry ; Animals ; Anthracenes/pharmacology ; Binding Sites ; Biotinylation ; Crystallography, X-Ray ; Enzyme Inhibitors/pharmacology ; Fluorescence Resonance Energy Transfer ; Glutathione/metabolism ; Humans ; Imidazoles/pharmacology ; Inhibitory Concentration 50 ; Isoleucine/chemistry ; Kinetics ; MAP Kinase Signaling System ; Mitogen-Activated Protein Kinase 10/chemistry ; Models, Biological ; Models, Chemical ; Models, Molecular ; Mutation ; Phosphorylation ; Point Mutation ; Protein Binding ; Protein Folding ; Pyrimidines/pharmacology ; Valine/chemistry ; p38 Mitogen-Activated Protein Kinases/metabolism |
Chemical Substances | Amino Acids ; Anthracenes ; Enzyme Inhibitors ; Imidazoles ; Merck Y compound ; Merck Z compound ; Pyrimidines ; Isoleucine (04Y7590D77) ; pyrazolanthrone (1TW30Y2766) ; Adenosine Triphosphate (8L70Q75FXE) ; Mitogen-Activated Protein Kinase 10 (EC 2.7.1.-) ; p38 Mitogen-Activated Protein Kinases (EC 2.7.11.24) ; Glutathione (GAN16C9B8O) ; Valine (HG18B9YRS7) ; Alanine (OF5P57N2ZX) |
Language | English |
Publishing date | 2005-06-15 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 523-x |
ISSN | 1096-0384 ; 0003-9861 |
ISSN (online) | 1096-0384 |
ISSN | 0003-9861 |
DOI | 10.1016/j.abb.2005.04.013 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uc I Zs.237: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.